Sign in

Fluicell

@fluicell.com
114 followers 272 following 50 posts

Transforming how we treat diseases with high precsision tissue solutions. We are developing advanced human cardiac drug screening models and tissue-based type 1 diabetes therapeutics. 👉 www.fluicell.com

PostsRepliesMedia
Fluicell @fluicell.com · 04/02/2026
Today on the World Cancer Day, we are highlighting the work of our partner Ambusol. Meet Ambusol's CEO Maximilian Telander and learn about their ambition to create new high precision therapeutics targeting gliblastoma. 👉 www.fluicell.com/news/changin...
Person dressed in blue lab clothes working in front of a microscope
000
Fluicell @fluicell.com · 04/12/2025
We installed a Biopixlar bioprinting system at @crick.ac.uk this week. Big thanks to amazing team at Making Lab for the smooth setup and warm welcome. Getting to see your facilities firsthand and hear about your research has been truly inspiring.
Two researchers using a Biopixlar bioprinting system. Both researchers are looking at a computer monitor showing a microscopic view of cells being dispensed on a surface, while one of them uses a gamepad to control the instrument.
021
Fluicell @fluicell.com · 25/09/2025
“Some of my proudest moments as a researcher have been when I have been able to solve problems by going back to my notes to figure out the cause.” 👋 Meet Anton Rydberg and find out how applying a scientific mindset has value in both research and training. 🔗 www.fluicell.com/people/anton...
010
Fluicell @fluicell.com · 16/09/2025
🔬 Last week we had the great pleasure of opening a new part of our lab at Fluicell focused on extended tissue and cell culture studies. This new space further enhances our ability to analyze tissue development, cell function and cell survivability over time.
022
Fluicell @fluicell.com · 05/09/2025
👋Join us in welcoming Rosa Lacordaire and Charlotte Cany from @espciparispsl.bsky.social who are doing a research internship with us. Supporting young researchers is an important part of Fluicell’s commitment to building the future of life science, and we’re excited to follow their progress.
141
Fluicell @fluicell.com · 02/09/2025
We are excited to announce that we are partnering with Ambusol to create groundbreaking new ways to treat cancer. Leveraging our microfluidic technology, we are developing a novel type of device for high precision drug delivery directly to the tumor. 🔗 www.fluicell.com/news/fluicel...
010
Fluicell @fluicell.com · 22/08/2025
🚀 We are excited to announce that we have received funding from Breakthrough T1D for a collaboration to develop type 1 diabetes tissue therapeutics. The collaboration combines our Nexocyte platfom with unique stem cell material to build designer islets for type 1 diabetes treatment.
A parent kissing a child. The child is looking slightly upwards and smiles. Text below the picture reads "Fluicell receives Breakthrough T1D project funding".
111
Fluicell @fluicell.com · 24/06/2025
🧪 Researchers at @uofcalifornia.bsky.social have discovered new ways to selectively target specific voltage-gated sodium channels, affecting neuronal excitability. Their results can enable more precise ways to treat epilepsy and other neurological conditions. 🔗 www.fluicell.com/news/selecti...
011
Fluicell @fluicell.com · 14/03/2025
We are excited to announce that our technology for generating three dimensional biological tissues has been granted a patent in the EU. The technology is the foundation for our tissue-based products for regenerative medicine and drug development targeting type 1-diabetes and cardiac disease.
Microscope image of a bioprinted organoid. The image is partly covered by a white donut shape. Black text against a yellow background reads "Fluicell tissue technology patent granted in the EU".
120
Fluicell @fluicell.com · 25/02/2025
Can light be a tool for labeling living cells? In a new study from researchers at @harvard.edu and Chinese Academy of Medical Sciences, Sarah Innes-Gold et al. present a method for light-activated cell labeling with high precision. Read more on our website. 🔗 www.fluicell.com/news/scienti...
Microscope image showing cell fluorescently labeled in a crosshatch pattern. Text in the image reads "Publication spotlight: Tools for intersectional optical and chemical tagging on cell surfaces"
120
Fluicell @fluicell.com · 10/02/2025
🧪 On March 12, the BIRDIE consortium is gathering experts in organoids, organ-on-chip technology and kidney disease to discuss how andvanced in vitro models can transform drug development and biomedical research. 👉 birdieproject.eu/2025/02/07/f... #OrganOnChip #Science #Bioprinting #KidneyDisease
010
Fluicell @fluicell.com · 29/01/2025
Cardiovascular diseases are responsible for one third of all global deaths but represent only five percent of newly approved drugs. Using our human tissue technology, we are creating next-generation research solutions to transform the way we treat heart disease. 👉 www.fluicell.com/pipeline/hea...
Donut-shaped microscopy image of cardiac tissue against a light-grey background. Text on top of the image reads "human tissue solutions for cardiac health"
010
Fluicell @fluicell.com · 17/01/2025
To measure neuron activation, Jové et al. used our open volume microfluidic platform BioPen to deliver blood and blood components directly to the tip of the mosquito stylet. The intriguing results show how neurons respond selectively to specific blood components. #microfluidics #science
010
Fluicell @fluicell.com · 16/12/2024
🌟 This past Friday we said goodbye to our interns Claire and Rachel from ESPCI, Paris, with a not so traditional Lucia celebration. 🙌 It has been an absolute privilege and a great joy to have you on our team and we wish you the best of luck on your journey ahead.
Group picture with two persons in front dressed as Lucia, but with lab coats instead of white gowns.A person playing celloTwo persons dressed as Lucia, but with lab coats instead of white gowns, laughing.
031
Fluicell @fluicell.com · 21/11/2024
💜 We are excited to announce that a patent covering our unique microfluidic bioprinting technology has been granted in the EU. The patent is an important step forward in our mission to provide the next generation of tissue solutions for drug development and regenerative medicine. #bioprinting
040